Category: Industry News

Industry News

Latest

Ida Institute Partners with Nova Southeastern University

With this partnership, NSU is joining 31 other organizations in the Person-Centered Hearing Network (PCHN), a global coalition of key stakeholders in audiology, representing professionals, academia, and patient organizations – working together to improve hearing healthcare at a global scale.

Industry News

Latest

Starkey’s Evolv AI Certified by Apple MFi Program

Starkey announced that its newest line of hearing aids are now compatible with iPhone and iPad, making it possible for those with hearing loss to have hands-free conversations. With the release of iOS 15 and iPad OS 15 earlier this year, Apple has added support for bidirectional hearing aids, such as Starkey’s Evolv AI hearing aids which include new bidirectional streaming technology.

Industry News

Latest

Alpaca Audiology Purchases Main Line Audiology Consultants

“We are pleased to add Mainline Audiology to our growing list of hearing clinics,” said Alpaca President Brian Vesely. “Dr Kathy Landau Goodman and her practice have a phenomenal reputation in their local market and within the larger audiology community.”

Sensorion, Sonova Sign Research Collaboration

Sensorion and Sonova announced that they have signed a multi-year strategic collaboration with the aim of introducing genetic analysis to the routine diagnosis of progressive hearing loss in adults, thereby opening the way for “improved care through a combination of advanced therapeutic interventions and traditional hearing aids.”

Read More

Neuromod Opens USA HQ

Neuromod Devices Ltd, the Irish medical device company specializing in the treatment of tinnitus, has announced the establishment of Neuromod USA Inc, headquartered in Oak Brook, Ill. Three executives with significant experience in the hearing health industry have been appointed to the Neuromod USA leadership team as the organization prepares to enter the US market with its medical device for tinnitus treatment, pending approval from the Food and Drug Administration (FDA).

Read More

Demant A/S Releases 2021 Interim Financial Report

Based on expectations that “its strong business momentum and market share gains in Hearing Healthcare will continue in H2 – despite tailwind from the French reform not recurring to the same extent as in H1 – Demant upgrades its guidance for the Group’s organic growth rate for 2021 to 26-30% (previously 24-28%).”

Read More
Loading